Clinical trial design is evolving rapidly, driven by the growing complexity of development pipelines and mounting expectations from patients, sponsors and regulatory bodies. Across the industry, there is an increasing recognition that success is no longer just about robust science – it’s about finding the right balance between scientific rigour, operational feasibility and real-world relevance.
A well-designed protocol isn’t just the start of a clinical trial but the foundation of its success.
Learn more in this European Biopharmaceutical Review (EBR) article by Audrey Fortier, Director, Scientific Affairs at Indero.
